McKesson Corporation

NYSE:MCK

Market Cap

USD 90.16 B

Share Price

USD 721.83

Avg Daily Volume

1,060,452

Change (1 day)

0.13%

Change (1 year)

19.69%

Change (YTD)

26.66%

McKesson Corporation Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 1.24%

McKesson Corporation Operating Income Margin is 1.24% for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.72% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • McKesson Corporation Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 1.32%, a -16.90% change year over year.
  • McKesson Corporation Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 1.58%, a 85.83% change year over year.
  • McKesson Corporation Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 0.85%, a -140.27% change year over year.
  • McKesson Corporation Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -2.12%, a -296.39% change year over year.
Key data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin
Market news
Loading...
NYSE: MCK

McKesson Corporation

CEO Mr. Brian S. Tyler Ph.D.
IPO Date Nov. 10, 1994
Location United States
Headquarters 6555 State Highway 161
Employees 44,000
Sector 🏥 Health Care
Industries
Description

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Similar companies

MRK

Merck & Co., Inc.

USD 80.16

1.39%

ELV

Elevance Health Inc.

USD 372.42

-0.56%

COR

Cencora, Inc.

USD 293.13

-0.18%

6618.HK

JD Health International Inc.

USD 5.22

3.31%

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.06

1.80%

2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.50

1.42%

1099.HK

Sinopharm Group Co. Ltd.

USD 2.38

1.23%

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.

USD 5.95

4.00%

HIK.L

Hikma Pharmaceuticals PLC

USD 27.69

-0.53%

0874.HK

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

USD 2.19

1.10%

GALE.SW

Galenica AG

USD 106.45

1.23%

OPCH

Option Care Health, Inc.

USD 31.05

-1.52%

600079.SS

Humanwell Healthcare (Group) Co.,Ltd.

USD 2.88

-0.67%

3320.HK

China Resources Pharmaceutical Group Limited

USD 0.66

1.21%

AMRX

Amneal Pharmaceuticals, Inc.

USD 7.92

1.21%

600518.SS

Kangmei Pharmaceutical Co., Ltd.

USD 0.26

-0.24%

0867.HK

China Medical System Holdings Limited

USD 1.53

3.48%

7459.T

MediPal Holdings Corporation

USD 16.18

0.70%

600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

USD 4.54

-0.39%

600511.SS

China National Medicines Corporation Ltd.

USD 3.99

-1.41%

9987.T

Suzuken Co., Ltd.

USD 36.21

-0.67%

OGN

Organon & Co.

USD 9.80

0.51%

603858.SS

Shandong Buchang Pharmaceuticals Co., Ltd.

USD 2.22

-0.11%

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

USD 1.93

-0.60%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 13.05

0.46%

8129.T

Toho Holdings Co., Ltd.

USD 32.09

-0.95%

600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd.

USD 1.46

-0.33%

000028.SZ

China National Accord Medicines Corporation Ltd.

USD 3.46

-0.32%

600993.SS

Mayinglong Pharmaceutical Group Co., LTD.

USD 3.90

-0.87%

600129.SS

Chongqing Taiji Industry(Group) Co.,Ltd

USD 2.97

0.80%

LLY

Eli Lilly and Company

USD 770.64

1.04%

JNJ

Johnson & Johnson

USD 151.32

1.02%

ABBV

AbbVie Inc.

USD 183.76

-0.83%

UNH

UnitedHealth Group Incorporated

USD 300.68

-0.44%

RO.SW

Roche Holding AG

USD 339.66

0.85%

AZN.L

AstraZeneca PLC

USD 140.89

0.81%

AMGN

Amgen Inc.

USD 272.44

-5.84%

PFE

Pfizer Inc.

USD 24.03

0.25%

GILD

Gilead Sciences, Inc.

USD 106.19

-2.13%

SAN.PA

Sanofi

USD 96.16

0.29%

BMY

Bristol-Myers Squibb Company

USD 46.92

0.13%

CVS

CVS Health Corporation

USD 66.81

0.36%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

GSK.L

GSK plc

USD 18.97

0.58%

REGN

Regeneron Pharmaceuticals, Inc.

USD 511.92

0.43%

LONN.SW

Lonza Group AG

USD 688.40

0.56%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

0.15%

HLN.L

Haleon plc

USD 5.19

0.41%

SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

USD 19.36

0.52%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.87

1.96%

StockViz Staff

June 24, 2025

Any question? Send us an email